Oakstone The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology 2022

20 $

+ Include: 61 videos + 2 pdfs, size: 8.53 GB

+ Target Audience: fellows/trainees, practicing hematology and oncology

Description

+ Include: 61 videos + 2 pdfs, size: 8.53 GB

+ Target Audience: fellows/trainees, practicing hematology and oncology

+ Sample video: contact me for sample video

+ Information:

Elevate Your Hematology and Oncology CME

The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology is a case-based online CME course focused on improving overall knowledge and clinical competency. Prep for your board exam and stay current on basic principles, changing guidelines and therapeutic strategies. Practice improvement areas featured in the continuing medical education program include:

  • Acquired/Congenital Bone Marrow Failure
  • Thalassemia/Hemoglobinopathies
  • Transfusion Medicine
  • New Therapies (Pharmacology)
  • Infections of the Immunocompromised
  • Hematologic Malignancies (Acute/Chronic Leukemias; Myeloma/Lymphomas)
  • Thoracic Oncology (Head/Neck/Lung/Thyroid)
  • and many more…

Date of Original Release: June 30, 2022
Termination Date: June 30, 2025

Learning Objectives

At the conclusion of this activity, the participant will be able to:

  • Apply current/recommended hematology and oncology guidelines in clinical practice
  • Perform differential diagnosis of complex clinical presentations related to hematologic and oncologic disorders
  • Identify/apply current therapeutic options for specific hematologic and oncologic disorders
  • Review and interpret up-to-date literature relevant to clinical practice in hematology and oncology
  • Demonstrate knowledge of pathophysiology as it applies to management of hematology and oncology disorders
  • Apply knowledge gained to the ABIM certification/recertification hematology and oncology examinations

Intended Audience

The activity was planned for fellows/trainees, practicing hematology and oncology specialists (MDs), and other professional affiliates (internists with an interest in hematology and oncology) who are preparing to take ABIM board review or recertification examinations, or who seek CME activities to improve patient care in the areas of hematology and oncology medicine.

 

 

+ Topics:

1. Molecular Genetics of Cancer.mp4
2. Advances in Cancer Drug Development Part I – Chemotherapy _ Targeted Agents.mp4
3. Advances in Cancer Drug Development Part II – Modulation of the Tumor Microenvironment.mp4
4. Infections in Cancer Patients.mp4
5. Symptom Management in Patients with Cancer.mp4
6. Communication The Key to Excellence in End-of-Life Care.mp4
7. Biology of Hematopoietic Stem Cell Transplantation.mp4
8. Biology of Acute Leukemia and Myelodysplastic Syndromes.mp4
9. Acute Leukemias.mp4
10. Myelodysplastic Syndrome.mp4
11. Chronic Myelogenous Leukemia.mp4
12. Myeloproliferative Syndromes.mp4
13. Multiple Myeloma.mp4
14. Waldenstrom Macroglobulemia and Amyloidosis.mp4
15. Low Grade Lymphomas.mp4
16. Aggressive Non-Hodgkin Lymphoma.mp4
17. Hodgkin’s Lymphoma.mp4
18. Diagnosis and Treatment of CLL and Related B Cell Malignancies.mp4
19. Head and Neck Cancer.mp4
20. Natural History, Screening, and Small Cell Lung Cancer.mp4
21. Non Small Cell Lung Cancer – Part 1.mp4
22. Non Small Cell Lung Cancer – Part 2.mp4
23. Mesothelioma and Thymoma.mp4
24. Carcinoid and Neuroendocrine Tumors.mp4
25. Novel Approaches for the Management of Esophageal and Gastric Cancers.mp4
26. Pancreatic Cancer.mp4
27. Hepatobiliary Cancer.mp4
28. Anal Cancer _ Colorectal Cancers Part 1.mp4
29. Colorectal Cancers Part 2.mp4
30. Gastrointestinal Cancer Genetic Syndromes.mp4
31. Testicular Cancer.mp4
32. Renal and Bladder Cancer.mp4
33. Prostate Cancer Part I Overview and Management of Localized Disease.mp4
34. Prostate Cancer Part II Management of Disseminated Prostate Cancer.mp4
35. Melanoma.mp4
36. Sarcomas _ Gastrointestinal Stromal Tumors (GIST).mp4
37. Molecular Advances and Emerging Treatment Strategies in Ovarian Cancer.mp4
38. Cervical _ Endometrial Cancer.mp4
39. Neuro-oncology.mp4
40. Breast Cancer – Risk Factors, Genetics, Screening, and Prevention.mp4
41. Multimodality Therapy for Early Stage Breast Cancer Part 1 – Surgery and Radiation.mp4
42. Multimodality Therapy for Early Stage Breast Cancer Part 2 – Systemic Therapy.mp4
43. Management of Metastatic Breast Cancer.mp4
44. Breast Cancer Survivorship.mp4
45. Hematopoiesis and Cytokines.mp4
46. Acquired Bone Marrow Failure.mp4
47. Congenital Bone Marrow Failure.mp4
48. Hemophagocytic Syndromes and Related Immunodeficiencies.mp4
49. Anemia – An Overview .mp4
50. Iron Deficiency and Iron Overload.mp4
51. Immune Hemolytic Anemia.mp4
52. Non-immune Hemolytic Anemia.mp4
53. Sickle Cell Disease.mp4
54. Thalassemia and Other Hemoglobinopathies.mp4
55. Disorders of Neutrophils.mp4
56. Acquired Thrombocytopenias.mp4
57. Hemophilia.mp4
58. Von Willebrand Disease _ Congenital Platelet Disorders.mp4
59. Congenital and Acquired Thrombophilia.mp4
60. Use of Direct Oral Anticoagulants in Clinical Practice.mp4
61. Transfusion Medicine for the Clinician.mp4
476-Questions.pdf
476-Syllabus.pdf

Reviews

There are no reviews yet.

Be the first to review “Oakstone The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology 2022”

Your email address will not be published. Required fields are marked *